## Abstract We assessed 5 EBV specific assays for their capacity to effect serologic diagnosis of suspected NPC. The assays were the immunofluorescent assays, VCA IgA and EA IgA, the enzymeβlinked immunosorbent assays specific for EBNA 1 IgA or zta IgG and an EBV DNA assay. Serum samples were taken
Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma
β Scribed by Dewi K. Paramita; Jajah Fachiroh; Sofia M. Haryana; Jaap M. Middeldorp
- Book ID
- 116631375
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 795 KB
- Volume
- 42
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To evaluate applications of highly purified recombinant EBV DNAase in the diagnosis and prognosis of NPC, we tested sera from patients with NPC, other EBV-associated diseases and EBV-seropositive and -seronegative healthy subjects by immunoblotting and DNAase inhibitory assay. The results were compa
This volume intends to contribute to βtranslational medicine and biologyβ. By this, we mean a bi-directional process whose aim is to develop knowledge from basic science towards diagnostic and therapeutic applications and reciprocally to raise new questions for basic scientists. One general requirem
Head and neck tumors include nasopharyngeal carcinoma (NPC) and lymphoma. The differential diagnosis of these tumors is based on histology, immunocytochemical staining, and EBV serology. In rare cases it might be difficult to distinguish between NPC and lymphoma in HE section or biopsies. DNA hybrid